172 related articles for article (PubMed ID: 35265665)
1. Clinical Prognostic Value of the
Meng Y; Sun J; Zhang G; Yu T; Piao H
Front Mol Biosci; 2021; 8():770729. PubMed ID: 35265665
[TBL] [Abstract][Full Text] [Related]
2. Bioinformatic analysis of PLOD family member expression and prognostic value in non-small cell lung cancer.
Qi Q; Huang W; Zhang H; Zhang B; Sun X; Ma J; Zhu C; Wang C
Transl Cancer Res; 2021 Jun; 10(6):2707-2724. PubMed ID: 35116582
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive Analysis of the Expression, Prognosis, and Biological Significance of PLOD Family in Bladder Cancer.
Chen R; Jiang M; Hu B; Fu B; Sun T
Int J Gen Med; 2023; 16():707-722. PubMed ID: 36872941
[TBL] [Abstract][Full Text] [Related]
4. Overexpressing PLOD Family Genes Predict Poor Prognosis in Pancreatic Cancer.
Zhang J; Tian Y; Mo S; Fu X
Int J Gen Med; 2022; 15():3077-3096. PubMed ID: 35330878
[TBL] [Abstract][Full Text] [Related]
5. PLODs are overexpressed in ovarian cancer and are associated with gap junctions via connexin 43.
Guo T; Gu C; Li B; Xu C
Lab Invest; 2021 May; 101(5):564-569. PubMed ID: 33483598
[TBL] [Abstract][Full Text] [Related]
6. Overexpressing PLOD family genes predict poor prognosis in gastric cancer.
Li SS; Lian YF; Huang YL; Huang YH; Xiao J
J Cancer; 2020; 11(1):121-131. PubMed ID: 31892979
[TBL] [Abstract][Full Text] [Related]
7. Identification of PLOD Family Genes as Novel Prognostic Biomarkers for Hepatocellular Carcinoma.
Yang B; Zhao Y; Wang L; Zhao Y; Wei L; Chen D; Chen Z
Front Oncol; 2020; 10():1695. PubMed ID: 33014843
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of LIMK1 Is Correlated With Poor Prognosis and Immune Infiltrates in Lung Adenocarcinoma.
Lu G; Zhou Y; Zhang C; Zhang Y
Front Genet; 2021; 12():671585. PubMed ID: 34149814
[TBL] [Abstract][Full Text] [Related]
9. [Construction and Validation of Prognostic Risk Score Model of Autophagy Related Genes in Lung Adenocarcinoma].
Zhou J; Wang X; Li Z; Jiang R
Zhongguo Fei Ai Za Zhi; 2021 Aug; 24(8):557-566. PubMed ID: 34256900
[TBL] [Abstract][Full Text] [Related]
10. Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase Family: Novel Prognostic Biomarkers and Tumor Microenvironment Regulators for Lower-Grade Glioma.
Gong S; Wu C; Köhler F; Meixensberger J; Schopow N; Kallendrusch S
Front Cell Neurosci; 2022; 16():838548. PubMed ID: 35250490
[TBL] [Abstract][Full Text] [Related]
11. Protein phosphatase 1 regulatory subunit 3G (PPP1R3G) correlates with poor prognosis and immune infiltration in lung adenocarcinoma.
Zhuo X; Chen L; Lai Z; Liu J; Li S; Hu A; Lin Y
Bioengineered; 2021 Dec; 12(1):8336-8346. PubMed ID: 34592886
[TBL] [Abstract][Full Text] [Related]
12. The relationship between PLOD1 expression level and glioma prognosis investigated using public databases.
Tian L; Zhou H; Wang G; Wang WY; Li Y; Xue X
PeerJ; 2021; 9():e11422. PubMed ID: 34040895
[TBL] [Abstract][Full Text] [Related]
13. Construction of the optimization prognostic model based on differentially expressed immune genes of lung adenocarcinoma.
Zhai Y; Zhao B; Wang Y; Li L; Li J; Li X; Chang L; Chen Q; Liao Z
BMC Cancer; 2021 Mar; 21(1):213. PubMed ID: 33648465
[TBL] [Abstract][Full Text] [Related]
14. A Human Pan-Cancer System Analysis of Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase 3 (PLOD3).
Gong S; Duan Y; Wu C; Osterhoff G; Schopow N; Kallendrusch S
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576068
[TBL] [Abstract][Full Text] [Related]
15. Identification of ALG3 as a potential prognostic biomarker in lung adenocarcinoma.
Yuan Y; Xie B; Guo D; Liu C; Jiang G; Lai G; Zhang Y; Hu X; Wu Z; Zheng R; Huang L
Heliyon; 2023 Jul; 9(7):e18065. PubMed ID: 37539167
[TBL] [Abstract][Full Text] [Related]
16. A new prognostic model for
Li Q; Liu XL; Jiang N; Li QY; Song YX; Ke XX; Han H; Luo Q; Guo Q; Luo XY; Chen C
J Thorac Dis; 2023 Apr; 15(4):1919-1934. PubMed ID: 37197482
[TBL] [Abstract][Full Text] [Related]
17. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma.
Zuo S; Wei M; Wang S; Dong J; Wei J
Front Immunol; 2020; 11():1218. PubMed ID: 32714316
[No Abstract] [Full Text] [Related]
18. PLOD Family: A Novel Biomarker for Prognosis and Personalized Treatment in Soft Tissue Sarcoma.
Gong S; Schopow N; Duan Y; Wu C; Kallendrusch S; Osterhoff G
Genes (Basel); 2022 Apr; 13(5):. PubMed ID: 35627171
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value and immune infiltration of a novel stromal/immune score-related P2RY12 in lung adenocarcinoma microenvironment.
Yu L; Cao S; Li J; Han B; Zhong H; Zhong R
Int Immunopharmacol; 2021 Sep; 98():107734. PubMed ID: 34175738
[TBL] [Abstract][Full Text] [Related]
20. High expression of glycolysis-related
Yu H; Yu Z; Qin C; Bian T; Shi M
J Thorac Dis; 2022 Sep; 14(9):3488-3499. PubMed ID: 36245582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]